Hamilton Lane Advisors’s Humacyte HUMA Stock Holding History

Hamilton Lane Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.1K	Hold	21,893	–	–	0.01%	14
2026 Q1	$13.3K	Hold	21,893	–	–	0.01%	20
2025 Q4	$21K	Hold	21,893	–	–	0.01%	26
2025 Q3	$38.1K	Hold	21,893	–	–	0.02%	20
2025 Q2	$45.8K	Hold	21,893	–	–	0.03%	14
2025 Q1	$37.3K	Buy	+21,893	New	+$82.2K	0.03%	14
2024 Q4	–	Sell	-21,893	Closed	-$119K	–	19
2024 Q3	$119K	Hold	21,893	–	–	0.1%	15
2024 Q2	$105K	Hold	21,893	–	–	0.08%	20
2024 Q1	$68.1K	Hold	21,893	–	–	0.05%	17
2023 Q4	$62.2K	Hold	21,893	–	–	0.03%	25
2023 Q3	$64.1K	Sell	21,893 -30,800	-58%	-$102K	0.04%	30
2023 Q2	$151K	Hold	52,693	–	–	0.07%	49
2023 Q1	$163K	Hold	52,693	–	–	0.05%	54
2022 Q4	$111K	Hold	52,693	–	–	0.04%	62
2022 Q3	$172K	Buy	+52,693	New	+$202K	0.06%	58

Other funds holding HUMA

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

UAS

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CWA

Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

VMMC

V.M. Manning & Co Greenville, South Carolina $117M AUM

Hamilton Lane Advisors's HUMA Position: Q2 2026 in Review

Hamilton Lane Advisors held its Humacyte (HUMA) position steady in Q2 2026 at 21,893 shares worth $17.1K. The position accounts for 0.01% of the portfolio, ranked #14.

Hamilton Lane Advisors first reported a position in HUMA in Q3 2022 and has held it in 15 quarters since. The position peaked at $172K in Q3 2022. 41 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

Hamilton Lane Advisors held 21,893 shares of Humacyte worth $17.1K as of Q2 2026.
Hamilton Lane Advisors left its Humacyte share count unchanged in Q2 2026.
Humacyte made up 0.01% of Hamilton Lane Advisors's portfolio in Q2 2026, its #14 holding.
Hamilton Lane Advisors first reported a position in Humacyte in Q3 2022 and has held it in 15 quarters since.
Hamilton Lane Advisors's Humacyte position peaked at $172K in Q3 2022.
41 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Hamilton Lane Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.